Using DNA methylation to understand biological consequences of genetic variability
- PMID: 22123027
- PMCID: PMC3304508
- DOI: 10.1159/000333097
Using DNA methylation to understand biological consequences of genetic variability
Abstract
The advent of high-content genomic mapping technologies has provided numerous clues about the genetic architecture of complex disease and the tools with which to understand the biological framework resulting from this architecture. We believe that understanding and mapping epigenetic marks, in particular DNA methylation, which is suited to such assays, offers a timely opportunity in this context. Here, we make an argument for this work, describing this opportunity, the likely path ahead, and the problems and pitfalls associated with such work.
Copyright © 2011 S. Karger AG, Basel.
References
-
- Hardy J, Trabzuni D, Ryten M. Whole genome expression as a quantitative trait. Biochem Soc Trans. 2009;37:1276–1277. - PubMed
-
- Mill J. Toward an integrated genetic and epigenetic approach to Alzheimer's disease. Neurobiol Aging. 2011;32:1188–1191. - PubMed
-
- Doi A, Park IH, Wen B, Murakami P, Aryee MJ, Irizarry R, Herb B, Ladd-Acosta C, Rho J, Loewer S, Miller J, Schlaeger T, Daley GQ, Feinberg AP. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet. 2009;41:1350–1353. - PMC - PubMed
-
- Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, Cui H, Gabo K, Rongione M, Webster M, Ji H, Potash JB, Sabunciyan S, Feinberg AP. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet. 2009;41:178–186. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
